Assenagon Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,623
| Closed | -$471K | – | 1181 |
|
|
2025
Q1 | $471K | Buy |
16,623
+1,645
| +11% | +$46.6K | ﹤0.01% | 1006 |
|
|
2024
Q4 | $623K | Buy |
14,978
+1,819
| +14% | +$75.6K | ﹤0.01% | 1148 |
|
|
2024
Q3 | $879K | Buy |
13,159
+5,807
| +79% | +$388K | ﹤0.01% | 1133 |
|
|
2024
Q2 | $873K | Buy |
7,352
+843
| +13% | +$100K | ﹤0.01% | 1108 |
|
|
2024
Q1 | $694K | Buy |
6,509
+530
| +9% | +$56.5K | ﹤0.01% | 1111 |
|
|
2023
Q4 | $595K | Sell |
5,979
-1,083
| -15% | -$108K | ﹤0.01% | 1178 |
|
|
2023
Q3 | $729K | Buy |
7,062
+260
| +4% | +$26.9K | ﹤0.01% | 1088 |
|
|
2023
Q2 | $826K | Sell |
6,802
-1,318
| -16% | -$160K | ﹤0.01% | 980 |
|
|
2023
Q1 | $1.25M | Sell |
8,120
-736
| -8% | -$113K | ﹤0.01% | 955 |
|
|
2022
Q4 | $1.59M | Buy |
8,856
+1,075
| +14% | +$193K | 0.01% | 856 |
|
|
2022
Q3 | $920K | Buy |
7,781
+5,533
| +246% | +$654K | ﹤0.01% | 923 |
|
|
2022
Q2 | $321K | Sell |
2,248
-803
| -26% | -$115K | ﹤0.01% | 1266 |
|
|
2022
Q1 | $526K | Buy |
3,051
+350
| +13% | +$60.3K | ﹤0.01% | 1149 |
|
|
2021
Q4 | $686K | Sell |
2,701
-226
| -8% | -$57.4K | ﹤0.01% | 1091 |
|
|
2021
Q3 | $1.13M | Buy |
+2,927
| New | +$1.13M | ﹤0.01% | 829 |
|